Cortland Associates Inc. MO Sells 48,495 Shares of The Cigna Group (NYSE:CI)

Cortland Associates Inc. MO lessened its holdings in The Cigna Group (NYSE:CI) by 27.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 126,944 shares of the health services provider’s stock after selling 48,495 shares during the quarter. The Cigna Group accounts for 4.0% of Cortland Associates Inc. MO’s investment portfolio, making the stock its 12th largest position. Cortland Associates Inc. MO’s holdings in The Cigna Group were worth $35,054,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of CI. Ulland Investment Advisors LLC grew its stake in shares of The Cigna Group by 2,500.0% during the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after acquiring an additional 100 shares during the period. Prospera Private Wealth LLC purchased a new stake in shares of The Cigna Group in the 3rd quarter valued at about $37,000. ORG Wealth Partners LLC purchased a new stake in shares of The Cigna Group in the 4th quarter valued at about $34,000. Harbor Capital Advisors Inc. purchased a new stake in shares of The Cigna Group in the 3rd quarter valued at about $45,000. Finally, Intact Investment Management Inc. purchased a new stake in shares of The Cigna Group in the 3rd quarter valued at about $69,000. Institutional investors own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on CI shares. Stephens reiterated an “overweight” rating and set a $410.00 price objective on shares of The Cigna Group in a research report on Friday, November 1st. Barclays increased their price objective on The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. StockNews.com lowered The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Cantor Fitzgerald reiterated an “overweight” rating and set a $400.00 price objective on shares of The Cigna Group in a research report on Wednesday, October 23rd. Finally, Piper Sandler reiterated an “overweight” rating and set a $394.00 price objective (up from $392.00) on shares of The Cigna Group in a research report on Tuesday, November 5th. One research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $395.93.

The Cigna Group Stock Up 0.2 %

Shares of NYSE:CI opened at $303.49 on Thursday. The stock has a market capitalization of $84.42 billion, a price-to-earnings ratio of 28.63, a PEG ratio of 0.78 and a beta of 0.54. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71. The stock has a fifty day simple moving average of $296.45 and a two-hundred day simple moving average of $325.14. The Cigna Group has a 12-month low of $262.03 and a 12-month high of $370.83.

The Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, topping analysts’ consensus estimates of $7.22 by $0.29. The firm had revenue of $63.70 billion during the quarter, compared to analyst estimates of $59.58 billion. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The business’s quarterly revenue was up 29.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.77 earnings per share. On average, research analysts anticipate that The Cigna Group will post 28.5 earnings per share for the current fiscal year.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.